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The KRT5 and KRT14 genes encode the proteins 
keratin 5 and 14, respectively, which are the printary 
structural components of the 10-nm intermediate 
filaments of the l11itotic epidermal basal cells . A 
single mutation in either gene can disrupt the keratin 
intermediate filament cytoskeleton, resulting in the 
skin fragility and blistering that is characteristic of 
the group of inherited disorders known as epidermol-
ysis bullosa simplex. We have established a mutation 
detection system that facilitates KRT5 gene analysis 
from leukocyte genomic DNA, obviating the need for 
a skin sample or keratinocyte culture for cDNA syn-
thesis. KRT5 intronic regions that flanked each exon 
were sequenced and sets of facing intronic pril11ers 
were designed for specific amplification of each of 
T he mitotic b~sa l cells of the epidermis coordin~te l y express the KR. T5 ~nd KR T14 genes, which encode the ker~tin 5 and keratin 14 proteins , respectively. These proteins <I~semble into <In O'-helic~ 1 coil ed-coil obhgate hete rodlllle r. thousands of w luch polymer-
ize to form the 1 O-nm keratin intermediate fi lament (KIF) cytoskel-
etal netwo rk of basal ce Us. Multiple lines of evidence have dem-
onstrated that disruptio ll of basal KlFs is the underl yin g pathology 
of the major class of inherited skin fragility disorders known 
coll ective ly ' IS epiderm o lys is bullosa simpl ex (EBS), which are 
characteri zed primarily by basa l ceU lys is and nonscarring intraepi-
derma l blistering after mi ld mec hanical trauma (Bonifas c/ ai, 1991; 
Coul ombe c/ aI, 1991; Fin e c/ aI, 1991) . Dominant EBS disease is 
ca used by a heterozygous mutation in either KRT5 or KRT14 that 
produces an altered keratin mo lecu le that interacts in a do minan t-
negative fa shio n with its normal keratin partn er to disrup t K IF 
st ru ctu re and fun ctio n. There is a good positi ve correla tion be-
tween the extellt and sevetity of b li stering with the degree of KIF 
d isrupti on o bserved by e lectron microscopy (Letai c/ ai, 1993; 
S teinert e/ aI, 1993 ) . Of the nin e KJl...T5 and 13 KJ.l...T14 uniqu e 
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the nine KRT5 exons. Direct sequencing of KRT5-
al11plified exons identified three novel missense mu-
tations. One mutation recurred in two unrelated 
patients with sporadic EBS . This glutalTIate to lysine 
substitution (E477K), located in the highly conserved 
KLLEGE 1110tif at the end of the central rod dOl11ain, 
is the third recurrent mutation identified in dominant 
epiderlTIolysis bullosa siInplex disease. The corre-
sponding glutal11ate in keratin 2e was previously 
reported to be frequently mutated in ichthyosis bul-
losa of Siel1lens, suggesting that this highly con-
served residue may be a potentiallnutational hot spot 
in other type II keratins or nonkeratin intermediate 
filament proteins . Key 1V00'd: illterm ediate filamellts. 
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l11uta tio ns reported to d ate, aU but one are singl e-base-pair missense 
mutations (Boni f.1s e/ ai, 1991; Coulombe el ai, 1991; Lanc cf al. 
1992; C han el aI , 1993; Compton , 1994; Yaminishi e/ aI , 1994; 
C hen c/ ai, 1995 ; Ehrlich ci aI , 1995; H achisuka e/ ai, 1995; Stephens 
l'I aI, 1995) with a onc-codon de le tion as the exception (C hen e/ al. 
1993). Most. but not all , amino acid substitutions in the evolution-
arily conserved terminal segments of the central rod domain ha ve 
been reported in patients that have chara cteristi c clumps of basa l 
KIFs that are pathognomoni c for a severe form of dominant EBS 
disease known as EI3S subtype Dowling-Meara (EBS-DM) (Anton-
Lamprecht and Schnyder, 1982). Amino ac id subs titutions in the 
subtermina l and / or centra l regi ons o f the rod o r in the head domain 
have been identifi ed in patients with milder disease, which can be 
generalized (EBS subtype Koebncr) 01' primarily limited to hands 
and feet (EBS subtype Webcr-Cockayn e) (Fine c/ ai, 199 1) . 
R ecessively inherited EBS disease occurs rare ly; in two patients the 
m olecular defect was a ho mozygous null mutatio n of both KR.T14 
alleles resulting in an absence of basal KIFs (C han e/ al. 1994; Rugg 
c/ aI, 1994). The phenotype of EBS patients and KR T 14 transgeni c 
mice (Vasser e/ al . 199 1) have provided compe ll in g evid ence of a 
ro le for basal KJFs in mainta ining the integriry of basal keratinocyte 
cells and ep idermal stru cture. 
W e initiated sequence analyses of KRT5 introns to design 
intronic primer sets that specifically amplify each of the nine KR TS 
exom . These primer sets would fac i.litate the identifica tion of 
KRT5 mutations by amplifica tion of genomic DNA samples of 
patients and obviate the need for skin bio psy o r cultured keratin o-
cytes for cON A synthesis, permit the identifi ca tion of intronic base 
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F ig ure 1. KRTS gen e structure and peR primer se ts. 1<J"l.. T5 "xons 
(boxes) . intl'on size, and location of primers used for exoni c ampli fication arc 
ind icated. Forward primers are above the KRTS gene schematic diagram 
and reverse primers arc below. Primers arc 5' --;. 3'; most prod uct sizes arc 
approx imate . Intron 5 was estimated at 360 bp. 
m u tatio n s th a t m ay underli e spli c ing defects , an d en sure specific 
amp lificatio n of KRT5 rath er th an th e hig hl y homologo us KJ~T6 
gene. By u sin g these prime r sets to screen gen om ic DNA fi'o m 
e ithe r peri p h era l bl ood o r immo rtalized Iympho bhl stoid ce ll lines of 
EBS p ati e n ts , we de tected th ree n ovel mu tatio n s. in c luding o n e 
that recurre d in a secon d unre lated pa ti en t. 
MATER.I ALS AND METHODS 
Patient s Patients we re ascerta ined by referra l to the National Epidermol-
ys is Bullosa Registry alldlor di rectly to o lle of the authors (V.P.S.). Each of 
the fo ur patien ts described were sporadic cases of EB5; no o ther filln il y 
members were affected . Patients E81 8 - 3. EB24-3, alld EB26-3 carried a 
diagnosis of EBS-D M based on c1 illic,'] presentation and electron micro-
scopic observation of circumscribed cl umps of KIF in basal ce ll s. T he 
phenotype of patient EB34 - 1 was illdeterminant. C linica ll y, her find ings 
were consistent with EBS-D M based 0 11 generalized b li stering in inf.1ncy. 
which progressed to herpetiform is lesions with ke ratoderma in childhood. 
O n electron I11 icroscopic cXiunination , however. 11 0 clulll ping of kcr;1 rin 
fi laments was fo und. EB34-1 was also remarkable for mu ltiple congeni tal 
anolll ali es , incl uding a ventricu lar septa l defect. congenita l persistent h),-
perp l<lsric vitreous cataract on the left, mild developmenta l delays (paticnt 
had meningitis at age 2 mol. and unilatera l cleft lip and palate . 
KRTS Gen e Analys is and Mu t at io n I d e ntification Pairs of cxonic 
KRT5 primers Rankin g each in tron inse rtion site were chosen from the 
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published cDNA sequence (Eckert and Ro rke. J 988) fo r ampli fic<ltion of 
c<lch in tron. Polymerase chain reaction (PCR.J-amp li fied products ofKR T5 
in trons were sequenced directly (Kogan and Gitschier. 1. 990), and the DNA 
seq uences ha ve been sub ln ittcd to the Gcnb:l l1 k database under accession 
num bers U05838 through U05849. F igure 1 gives the intronic primer sets 
deve loped for the ampli fi cation of each K.R T5 exon. PCR of 250 ng of 
genomic DNA purified from either periphera l blood leukocytes or immor-
ta li zed Iymphobl<lsts was performed in a 50-I.d vo lume with all four 
deoxynucleotide tri phosphates (each at 200 ILM), each primer at 450 nM. 2 
un its of AmpliTaq polymerase. 5 ILl of 1 OX PC R bu fre r (Perkin-Elmer, San 
Francisco . CA), and 1. 5 mM MgClz fo r 35 cycles ,l[ 94 °C fo r 1 min. 55°C 
for 1 mill . alld 72°C fo r 1 min. Exceptions included PCR with primer sets 
B I /B2 and ClIC2 where the MgCI2 was 1.0 rn M. and primer sets C I / C2 
and H1/ H2 with an allllea ling temperature of 61°C. 
Alle le-specific o ligon ucleotide (ASO) hybridization was used to screen 
normal KItTS all eles fo r each muta tion. T he KRT5 gene segment carrying 
each muta tion was ampli fi ed from the genomic D N A of between 26 and 46 
unre lated cl inically unafrected indi viduals and app lied to two duplicate 
Zetabind membranes with a slot-blot ap paratus. along with one control 
sample ampli fied from a patient carrying the I11u tation. Duplicate mem-
branes were prehybridized in 0 .25 M NazHPO .,. 7')1" sodiu lll dodecyl sul fate 
at 50· C for 10 min. after which either 'Y-H P-Iabe led normal o r Ill uta nt ASO 
was added and hyb ridi zed for 60 mill . Membra nes wen.! washed in GX SSC. 
U. 1 % sodiu m dodecyl sul f.,te fo r '10 min at 65· C and exposed to XA R-
OMAT fi lm . T he gene segment ca rrY'ing the N 1765 mutation was amp li fied 
with primers A2 and A3 (F ig 1) and hybrid ized to the ASO primers 
AAGACCCTCA(A/G)CAATAAGTTTG. with the alternate normallmu-
ta nt base pa ir indicated in pa rentheses. T he gene segment carr)~ng the 
F I79S I11u tatiO Il was ampli fied with primers A2 and A3 (F ig 1) and 
hyb rid ized to the ASO primers AACAATAAGT(T/C)TGCCTCCTTC. 
T he gene segment carrying the E'177K Illu tation was am pli fied with primers 
G1 and G2 (Fig 1) and hybridized to the ASO primers CTGGAGGGC(GI 
A)AGGAATGCAG . 
R.ESULTS 
To determine th e sequ en ce o f KItTS introns, we te sted whether 
th e PC R. could am pli fy across each of th e e ig h t intron s by using 
fl an king exonic prim e rs des igne d fro m th e previo u sly re po rted 
KRT5 cD N A seq u e nce (Eckert an d Rorke , 1988) . To minimize the 
poss ibili ty of th e primers ann ea ling to ke rati n 6 cDNA seq uences, 
w hic h arc 86°;', h o m o logous to KRT5 (Tyn e r ct ai, 1985), a t least 
o ne o f each prim e r p air was des ign e d to overlay a base(s) that 
differed between th e two gen es. D iscre te PC R pro du cts were 
obtain e d fo r each o f th e e ig h t in tro n s, seq u e n ced in par t or in 
w h o le, and subm itted to th e Genbank data base (Materials alld 
Methods). T h e seque n ces a t each of th e sp lice d o n or an d acceptor 
sites m atch e d the k nown con sen su s sequ e n ces. In tron sizes are 
g iven in F ig 1.. Fro m these in t ro ni c sequ e n ces, fac ing p rim er pairs 
were design e d that fl an ked each exon to f.1c ili ta te exon-specific 
amplifi catio n of KR T5. By u sing th e prim e rs g iven in F i g 1 , we 
determin ed th at each p rime r set amplifi ed a uniq ue exoni c pro duct 
of th e pre dicted size, w hic h w as con fi nne d as au th e n tic lUtTS by 
di rect sequence anal ysis (d ata not shown). Addi tio nal PC R primer 
sets a rc g iven fo r ampl ificatio n of exons 1 , 5, and 9, w h ich were 
a lso useful in sequ e n ce an d mu tatio n al an alyses (Fig 1). 
Novel mu tatio n s in fO lll" EBS patien ts w e re iden tifi ed by d irect 
sequencin g of KRT5 exon-specific ampli fica tion produ cts . As 
shown in F i g 2 , o ne a ll e le of patien t EB34 -1 carri ed an A -7 G 
substitu tion at b ase 527, w hich predicted a substi tu tio n of the 
as p aragi n e a t codo n 176 w ith a se rine res idu e (N1 76S) . T he second 
patie n t, EB24 - 3, h ad o ne a ll e le w ith aT -? C c h an ge at b ase 536, 
predic tin g a substitu t io n of phen ylalanin e at cod o n 179 with a 
serine res id u e (F179S). T h e third and fo urth patie nts, EB1 8 - 3 an d 
EB26 - 3, both ca rried th e same heterozygo us b ase su bstitu tion of 
G -? A at position 1429, w hi ch predi cted a g lu tami c ac id to lysine 
c han ge at codon 477 (E477K). Each of th ese fo ur patien ts were 
sp o radi c cases ofEBS and , as expected fo r appare n t new mu tations, 
th e ir clin ica lly un a ffected pare n ts did not carry th e b ase substitu tion. 
T h ese KItTS base substitu t io ns arc unli ke ly to be commo n neutral 
p o lym orphic sites, as th ey we re not o bserved in a screen of between 
52 and 92 KRT5 a ll e les /To m unre lated clinica ll y unaffected 
ind ividu als (Materials ami i\lJefhods and d ata not sh o wn). 
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RBQIKTL human K5 B IATYRKLLBG BCRL 
RBQI KS L human Kl E I ATYRTLLEG ESRM 
RBQI KTL human K2 BIATYRKLLEG BCRM 
REQI KTL human K3 EIATYRKLLEG EYS R 
RBQI KLL ASFID human K4 E IATYRKLLEG EYRM 
RHQI KS L SFID human vimcntin E IATYRKLLEG HSRI 
RBQI KS L SPID mouse K I E I GTYKKLL E G HI RM 
KEQI KTL frog K8 E IATYRKLLEG BSRL 
F igure 2. Keratin 5 111utations in EnS patients. Genomic DNA from immortali zed Iymphoblasto id celllillcs ofpatiellts was amplified by the pe R and 
seq uenced directl y; heterozygous base changes and their corresponding predi cted amino acid substi tutions are indicated . (A) Sequence frol11 patient £1334 -1. 
(B) Sequence fro m patient EB24 - 3. Both sequences we re amplified with primer sets A2 and A3 (Fig 1) and sequenced with primer A3. (C) Sequence of 
pa tient EO·18 - 3. amplifi ed with primer set G 'I and G2 (Fig 1) and seq uenced w ith primer Gl. (D) Schematic of the seconda ry structure of kera tin 5 showing 
tbe a -he li ca l domains or the central rod. tAo 1 E, 2A, and 213 and the evolutio nary conse rvatio n of amino acids at the residu es mutated in the EES patients 
(shaded). 
DISCUSSION 
T he sequences and PC R primers of KRT5 introns reported in this 
article will fac iliate mutational screenin g of genomic DNA samples 
of EBS patients, identifica tion of in tronic base changes that affec t 
sp licing, and specifi c amp lifi cation of KRT5 rath er than the highly 
hom ologous KRT6 gene. The KRT5-amplified exons o f patients 
can be sequenced direc tl y or cleaved with restric tion endonucleases 
to generate sm all er fi-agments suitable for mutational screening 
techniques such as sing le-strand confOl'mational polymorphism or 
didem .... ynucleotide fi ngerprinting (Orita et fll , 1989; Liu and Som-
mer, 1994) . 
By usin g these primers, we identified th ree nove l KIlTS missense 
m utations fi'om a total of 14 EBS-DM patients. T he pathogenicity 
o f these novel mutations is supported by multiple lin es of evidence. 
(i) T he c1illica ll y un affected parents of the four sporadic EBS 
patients did not carry the mut;ltions. (ii) Absence of these missense 
m utations in more than 45 normal KR T 5 allel es argues that they are 
unlikely to be ne utral polymorph isms. (iii) All three missense 
mutation s predic ted a substitution of a hig hl y conserved amino acid 
residue (Fig 2D) . In particular, the E477K mutation alters the 
second glutamate residue of the KLLEGE motif, the most evolu-
tionarily conserved m otif among all types of intermediate filament 
pro teins (Hatzfeld and Weber, 1991 ). (iv) Basal KIF abnormalities 
corre lated with the nature of the amino acid substitution . T he most 
conservative substitution involved polar residues (N176S) and 
occurred in patient EB34 -1 w ho had normal appearing basa l cell 
KIF . Patients EB18-3, 24-3, and 26 - 3 with dramatic amino acid 
substitu tions of an acidic glutamate with a basic lysine residu e 
(E477K) or of a hydrophobic phenylalanin e with a polar serine 
(F179S) had severely disrupted basa l KIFs typical of the EBS-DM 
phenotype_ (v) T hese novel mutations occurred in the terminal 
segments of the a -helical central rod domain (Fig 2D), regions 
where pre viously described KR.T5 and KRT1 4 missense mutations 
have been documented to have a dominant negative e ffect on KIF 
structure and/or function ;11 11 ;11'0 , ;11 11;110, and in transgenic animals 
(for example, Cou lombe ct fl l, 1991; Vasser el fl l, 1991 ; Lane C! fll , 
1992; Steinert et fll, 1993; Stephens et ai , 1995) . T he recurrent 
E4 77K mutation li es in the highl y conserved KLLEGE motif, w hich 
is important for fi lam ent assembly and stability (Letai et ai, 1992; 
1993; Wilson et ai , 1992) . 
The phe notype and genotype of patient EB34-1 w as remarkable 
in several ways. First, thi s patient's mutation is the third case o f an 
amino acid substi tution in a central rod terminal segment that does 
not resu lt in the circumscl;bed clumps of basal KlFs pathogno-
monic for EBS-DM (Yamanishi et ai, 1994; Stephens ct fl l , 1995). 
H er clinical phenotype, however, was most consistent with EBS-
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Table I. Recurrent and COITnDOn Mutations in Epidermolysis Bullosa Simplex 
Prcdic ted 
Kcratin Base alnin o Mutation in 
gene change" acid change CpG site 
KRT14 C -> T 37:1 R125C Yes 
Im.T14 G -> A37" RI 251-1 Yes 
KRT5 T -> G4 " ' /1 61 S No 
KRT14 C -> AM" A2740 No 
KltT14 T ->C " 5' L384P No 
KRT5 G -> A ' 4 2~ E477K Yes 
" Po!i ition is assumed to be th e A of the initiating AUG codon. 
M utation Frequency 
R .cclIrrCrlt 3 of 14 EllS-DM cases 
Recurrent 5 of 14 EBS-OM cases 
COJll 111 0n 11 of30 EBS-WC cases' 
Common 2 of 49 El3S cases 
C01111T10 11 2 of <I EBS-K cases' 
Recurrent 2 of 14 EBS-OM cases 
Rcfcrencc(s) 
Cou lombe el (//, 1991 
Stephens el (//, 1993" -
Chen et (//, 1995 
I-Iachjsuk" el a/, 1995 
Stephens, unpublished datab 
Coulombc el (//, 1991 
Stephens el ai, 1993" 
Chen er ai, 1995 
Stephens, unpublished datab 
Chan el a/, 1993" 
Ehrlich el ai, 1995" 
Stephens, unpublished data b 
Chen el ai, 1995" 
Bonifas el ai, 1991" 
I-Iachisuka el ai, 1995b 
This article 
II Reference for the frequency value . Other citat ions, wh ich cou ld not be used in rhe frequency Gllcllla tions due to lack of denominator value, arc given .liso . 
, EDS-W C. EBS subtype Weber-Cock"yne; EBS-K. EDS suhrype Kocbcr. 
DM. She was also remarkable for both EBS and multip le congenital 
anomalies . T h e identification of a heterozygous N176S missense 
mutation in KRTS disproved our o ri gina l hypothesis that the 
patient carried a contiguous gene deletion or rearrangemen t re-
sponsible for aJI her c1iJlicalmanifestations. T he multiple congenital 
anomalies are apparently co incident to her EBS disease. Because her 
constellation of extracutaneous findings was suggestive of velocar-
diofac ia l syndrome, Auorescen ce ill 5illl hybridization to test for the 
chromosome 22q deletion associated with this syndrome (Driscoll 
ct aI, 1993) was performed and was negative. 
T h e 1429 G -'> A substitution in KRTS is the third mutation 
documented to have recurred as a new mutation in unrelated 
EBS-DM patients. The other two recurrent mutations are in the 
first and second positions of KRT14 codon 125 (Table I). T he 
recurren ce of 'a ll three mutations is consistent with a mechanism 
in volving spontaneous deamination of a methylated cyti dine resi -
due in a CpG dinucleotide, which is a common molecular basis fo r 
human mutation (Cooper and Youssoufian, 1985; Stephens c/ aI, 
1993; Coulombe el aI, 1991). Our iden tifi cation of the KRT5 
E477[( muta60n, which recurred at a CpG site in sporadic patients 
EBS-3 and EB26 - 3, ha s di sproved an ea rli er hypothesis that 
mutations in K.RTS E'I77 were not observed because they were 
phenotypica lly subtle or le thal o r because this CpG site was 
ul1methylated (Letai el aI, 1993). Tn addition to o UI' observations of 
recurrent muta60ns ofKRT5 En 7, the corresponding glutamate of 
ke ratin 2e is a mutationa l hot spot in ichthyosis bullosa of Siemens 
(McLean et aI, 1994; Rothnagel e/ ai, 1994). D ue to the high degree 
of conservation of the KLLEGE motif, this glutamate may be a 
potentia l site of mutation in other type 11 keratins and perhaps even 
n onkeratin intermediate filament proteins. 
Although th e number of cases is small, the data indicate that 
DNA-based diagnosis may be informa6ve in a signifi cant number of 
cases. Ten of 14 (> 70'1.,) EBS-DM patients examined carried a 
mutation at one of three rec urrent mutation sites (Table I). 
Thirty-tive percent (11 of 30) of the EBS sub type Weber-Cock-
ayne patients exa m ined carried the same KI~TS mutation and two 
of four EBS subtype Koebner patients examined carried the sa me 
KRT14 mutation (Table I) . Consisten t with the hypothesis that 
many new hUJ11 ,1l1 muta60ns co mmonly occur by deaminati on of 
methylated CpG sites, a ll reculTent EBS mutations are at cytidine 
residu es in CpG dinucleotides (o r guanosi ne residues o n the 
complementary strand ; Table I). Other EBS muta60ns have been 
ascertained in multiple unre lated patients who inherited EBS fro m 
an affected parent (Table I) . T hese substitutions, however, sho uld 
be considered as common mutations ra th er than recurrent. A l-
though they have been ascertained in mul6ple unrelated pa6ents, 
each patient inherited the mutation from an affected parent and, 
therefore, there is no evidence that a new mutational event has 
recurred at a particu lar base pair. Comm on mutations may derive 
fro m a sin gle an ces tral , or founder, mutation that was inherited by 
seemingly unre lated fami lies (Ehrlich e/ aI, 1995). 
H/e Ihallk Ihe fall/ilies JiJl' Iheir parlicipalioll ill Ihis sllldy. This research IIIas 
s flpportedl,)' Grnlll PO'I A R 2 1557 frOIl/ Ihe Ull ilcd Slall's PIIMic Hea/lh Semice. 
DNA seq llellcillg "l KRT5 illlrolls ",as pfI.'1imlle(/ by Ihe MolcCII /ar Gel/{'Iic Core 
Labornl()/)' ,"'ppor/ed by Grnll l PO 1 I I R2155 7Ji'o fl, rhe Ull ited S tales Pllblic Hea/lh 
Sendcc. SOllie illr!i"ir!lIal patielllS lI'erc ascI'l'Ia illcd /hmllgh Ihe Nalio ll al Epider/llol-
ysis BII I/osa R~~islry (N01 AR2-2203). 
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